TC Biopharm (Holdings) Plc
TCBPY
$0.19
$0.00-0.11%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -51.48% | -45.78% | -47.94% | -79.17% | -45.85% |
| Total Receivables | -40.79% | -33.83% | -48.23% | -- | -34.82% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -6.83% | 4.12% | -7.49% | -- | 4.93% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 132.96% | 160.33% | 973.13% | -- | 5,030.67% |
| Total Current Assets | -0.44% | 11.25% | -20.58% | -- | -19.08% |
|
|
|||||
| Total Current Assets | -0.44% | 11.25% | -20.58% | -- | -19.08% |
| Net Property, Plant & Equipment | -21.55% | -12.34% | -14.15% | -- | -15.99% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -25.51% | -16.76% | 0.35% | -- | 17.60% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | -8.35% | 2.42% | -16.96% | -- | -16.38% |
|
|
|||||
| Total Accounts Payable | -25.87% | -17.16% | -1.77% | -- | 121.31% |
| Total Accrued Expenses | -10.59% | -0.09% | 56.31% | -- | 169.28% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 5.73% | 18.14% | 4.68% | -- | -1.59% |
| Total Finance Division Other Current Liabilities | 21.73% | 36.02% | -88.05% | -- | -96.82% |
| Total Other Current Liabilities | 21.73% | 36.02% | -88.05% | -- | -96.82% |
| Total Current Liabilities | -14.18% | -4.10% | -23.03% | -- | -45.20% |
|
|
|||||
| Total Current Liabilities | -14.18% | -4.10% | -23.03% | -- | -45.20% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -23.06% | -14.02% | -19.95% | -- | -12.00% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | -16.31% | -6.48% | -22.21% | -- | -39.75% |
|
|
|||||
| Common Stock & APIC | 26.75% | 41.64% | 147.65% | -- | 35.15% |
| Retained Earnings | -27.85% | -42.87% | -32.09% | -- | -27.98% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 10.16% | 23.10% | -0.69% | 232.99% | 757.00% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 10.16% | 23.10% | -0.69% | 232.99% | 757.00% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 10.16% | 23.10% | -0.69% | 232.99% | 757.00% |
|
|
|||||